Skip to content

Marketstatics

Menu
  • Home
  • About Us
  • Contact Us
Menu

Category: Pharmaceutical

HPO Oxlumo Peds Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Oxlumo (Lumasiran) Pediatric Market Size and Forecast The Oxlumo pediatric market, focused on treating Primary Hyperoxaluria Type 1 (PH1) in children, is a niche but high-value segment within the rare disease therapeutics…

HF Omecamtiv Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

HF Omecamtiv Market Size and Forecast The market for heart failure (HF) drugs is substantial, projected to grow at a 5.2% CAGR from $31.9 billion in 2022 to $53 billion by 2032…

AS Brodalumab Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Brodalumab Market Size and Forecast Brodalumab, a human monoclonal antibody targeting the IL-17 receptor A, is a key component of the broader IL-17 biologics market, primarily utilized for treating moderate-to-severe plaque psoriasis…

ALS NurOwn Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

ALS NurOwn Market Size and Forecast The market for Amyotrophic Lateral Sclerosis (ALS) therapeutics is undergoing transformation due to new drug approvals and pipeline candidates like NurOwn (autologous MSC-NTF cells). While a…

Prost Enzalutamide Generics Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Prost Enzalutamide Generics Market Size and Forecast The Prost Enzalutamide Generics market is poised for significant expansion following the patent expiration of the branded drug, Xtandi. Enzalutamide is a critical oral androgen…

Dep Auvelity Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Auvelity Market Size and Forecast The market for Auvelity (dextromethorphan-bupropion) is part of the broader Major Depressive Disorder (MDD) treatment landscape, which is valued in billions globally. Auvelity was approved in August…

UC Guselkumab Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Guselkumab in UC Market Size and Forecast Guselkumab (Tremfya), an IL-23 inhibitor, targets moderately to severely active Ulcerative Colitis (UC) in adults who have failed conventional, biologic, or JAK inhibitor therapies. Its…

SMA Zolgensma Peds Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

SMA Zolgensma Peds Market Size and Forecast Zolgensma, Novartis’s gene therapy for Spinal Muscular Atrophy (SMA), targets the pediatric population and represents a major market segment within the overall SMA treatment space….

Blad Nadofaragene Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Nadofaragene Firadenovec Market Size and Forecast Nadofaragene firadenovec (Adstiladrin) is a promising gene therapy for high-risk, BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC). The market size is currently driven by its niche application in…

Anx Zuranolone Market: Size, Forecast, Drivers, and Key Trends

Posted on November 29, 2025 by Nicole Green

Zuranolone Market Size and Forecast Zuranolone (Zurzuvae) is a novel neuroactive steroid indicated for Postpartum Depression (PPD) and is set to significantly impact the antidepressant landscape. Its market size is anticipated to…

Posts pagination

Previous 1 … 36 37 38 … 101 Next

Categories

  • Healthcare
  • Pharmaceutical
  • Uncategorized
©2025 Marketstatics | Design: Newspaperly WordPress Theme